Abbott Laboratories Stock price

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-01 pm EST 5-day change 1st Jan Change
118.6 USD -0.02% Intraday chart for Abbott Laboratories -0.70% +7.77%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2024 * 41.98B Sales 2025 * 44.93B Capitalization 206B
Net income 2024 * 6.03B Net income 2025 * 6.96B EV / Sales 2024 * 4.97 x
Net Debt 2024 * 2.65B Net cash position 2025 * 2B EV / Sales 2025 * 4.54 x
P/E ratio 2024 *
34.3 x
P/E ratio 2025 *
29.7 x
Employees 114,000
Yield 2024 *
1.84%
Yield 2025 *
1.97%
Free-Float 86.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.02%
1 week-0.70%
Current month-0.02%
1 month+3.61%
3 months+13.10%
6 months+15.33%
Current year+7.77%
More quotes
1 week
117.83
Extreme 117.83
120.45
1 month
110.58
Extreme 110.58
120.45
Current year
109.29
Extreme 109.29
120.45
1 year
89.67
Extreme 89.674
120.45
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 -
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 20-02-29
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-03-01 118.6 -0.02% 3,899,429
24-02-29 118.6 -1.17% 6,135,244
24-02-28 120 +0.54% 3,383,982
24-02-27 119.4 +0.60% 3,203,311
24-02-26 118.7 -0.64% 3,483,103

Delayed Quote Nyse, March 01, 2024 at 04:00 pm EST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (38%); - vascular devices (21%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (17.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (11.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (12.7%). Net sales are distributed geographically as follows: the United States (41.5%), Germany (5.4%), China (4.9%), Japan (4.4%), India (3.8%), Switzerland (3.1%), Canada (2.9%) and other (34%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
118.6 USD
Average target price
124.9 USD
Spread / Average Target
+5.31%
Consensus
  1. Stock
  2. Equities
  3. Stock Abbott Laboratories - Nyse
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW